Wendela L. de Ranitz‐Greven

Epilepsy, impaired functioning, and quality of life in patients with tuberous sclerosis complex

M. Vergeer, Wendela L. de Ranitz‐Greven, Maureen P. Neary et al. · Epilepsia Open · 2019 · 33 citations · Full text

Medicine, Neurology, Epilepsy +8

Advanced Glycation End Products, Measured as Skin Autofluorescence, During Normal Pregnancy and Pregnancy Complicated by Diabetes Mellitus

Wendela L. de Ranitz‐Greven, Lotte Kaasenbrood, Wendy K. Poucki et al. · Diabetes Technology & Therapeutics · 2012 · 26 citations

Medicine, Gynecology, Obstetrics +14

Advanced Glycation End Products, Measured as Skin Autofluorescence, at Diagnosis in Gestational Diabetes Mellitus Compared with Normal Pregnancy

Wendela L. de Ranitz‐Greven, Dieuwke C. Bos, Wendy K. Poucki et al. · Diabetes Technology & Therapeutics · 2011 · 19 citations

Medicine, Endocrinology, Obstetrics +17

Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM

Annelieke R. Müller, Michiel A. J. Luijten, Lotte Haverman et al. · BMC Medicine · 2023 · 18 citations · Full text

Education, Neurology, Functional Assessment +16

The long-term effect of mTOR inhibition on lipid and glucose metabolism in tuberous sclerosis complex: data from the Dutch TSC registry

Femke V. M. Mulder, Evelien F. H. I. Peeters, Jan Westerink et al. · Orphanet Journal of Rare Diseases · 2022 · 12 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17